Clinical Trial Update: A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of CD-008-0045 in patients with generalized anxiety disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• CD-008-0045

Snippet

Sponsor: ChemRar Research and Development Institute, LLC | Conditions: Anxiety Disorder Generalized | Phase 3 | Status: UNKNOWN